It has been estimated that 1 to 2% of the population in developed countries will experience a chronic wound over their lifespan. [1] Occurrence of chronic wounds are particularly common in growing elderly populations and those who are suffering from diabetes and obesity. [2] While there are several phases in wound healing (i.e., coagulation, inflammation, proliferation, and remodeling), [3] [4] [5] [6] chronic wounds are typically the result of prolonged and/or uncontrolled inflammation. [2, 7] Despite this, inflammation is an indispensable step in the wound healing process and sets the stage for proper regeneration by staving off infection, clearing the wound site of debris, and recruiting cells to the wound that play critical roles in tissue remodeling and re-vascularization. [3, 6, 8, 9] In fact, studies have
shown that suppressing the inflammatory response actually hinders proper wound healing. [4, 10] Macrophages play a key role in regulating the inflammatory response and in directing the transition to later stages of the wound healing process. [11] [12] [13] [14] [15] [16] [17] We and others believe that regulating the time at which macrophages transition from coordinating an inflammatory response ( Figure 1a , Phase 1 (red)) to coordinating later pro-healing stages of the wound healing process (Phase 2 (blue)) may be key to understanding the role of inflammation in Submitted to 2 2 wound healing and in developing improved treatment strategies. [18] [19] [20] For example, it is apparent that proper healing requires an inflammatory phase that eventually transitions into anti-inflammatory, pro-healing phases. [21, 22] However, it remains unknown how the duration of this inflammatory phase (Tih) impacts or can be used to optimize wound healing outcome.
Moreover, optimal durations are likely different for different wounds and for different patients.
This motivates the need for biomaterials that enable flexible control over the duration of this inflammatory period, as both an investigative and clinical tool.
Here, we propose a biomaterial system designed to deliver immunomodulatory cytokines in a manner that can potentially regulate the inflammatory period's duration in a flexible and on-demand manner. The inflammation phase can be initiated by establishing a population of pro-inflammatory M1 macrophages through the delivery of proteins that recruit macrophages and polarize them towards M1 phenotypes (Figure 1b, M0 to M1): for example, Monocyte Chemoattractant Protein-1 (MCP-1), [23, 24] and Interferon Gamma (IFN-γ). [25] Transition from inflammatory to healing phases requires establishing a population of antiinflammatory M2 macrophages (e.g., alternatively activated M2a, Mb, and Mc phenotypes).
This can be triggered through the delivery of other proteins at the wound site: for example, Interleukin-4 (IL-4), [26, 27] and Interleukin-10 (IL-10), [26, 27] ( for an inflammatory period to continue until, (iii) a magnetic gradient is applied that deforms the inner compartment, releasing anti-inflammatory cytokines, which would (iv) direct macrophages to take on pro-healing phenotypes. Such a material system could enable control Submitted to 3 3 over the inflammatory period's duration simply by applying a magnetic gradient (from simple hand-held magnets or electromagnets) at the time point at which one wishes inflammation to transition into an anti-inflammatory phase.
This two-compartment biomaterial system comprises an outer gelatin scaffold and an inner biphasic ferrogel (Figure 2a) . The outer compartment exhibited an interconnected macroporous structure designed to permit rapid cell infiltration (Figure 2b) . Also, by virtue of being made from gelatin (a hydrolyzed form of collagen), this gelatin scaffold presents binding motifs for cell binding, motility, and spreading. [28, 29] For the inner compartment, we utilized a biphasic ferrogel with an Fe3O4-laden region on the top half of the cylindrical gel and an Fe3O4-free, porous, and deformable region on the bottom (Figure 2c ). These biphasic ferrogels were designed to efficiently deform in the presence of a graded magnetic field (i.e., in the presence of fields emanating from simple hand-held magnets or electromagnets). When magnetically deformed, these gels would release molecular payloads stored in the Fe3O4-free region in a magnetically triggered manner. The particular ferrogel formulation adopted here (1 wt% alginate, 7 wt% Fe3O4, 2.5 mM adipic acid dihydrazide cross-linked, freeze-dried at -20ºC) was previously shown to be optimal in terms of providing magnetically triggered deliveries. [30, 31] The outer porous gelatin scaffold was designed to provide initial deliveries of proinflammatory cytokines and to recruit and permit the residence of macrophages. To test this compartment's ability to recruit and establish macrophage populations, RAW 264.7
macrophages were seeded at 10,000 cells per well in a 12-well plate on Day -1 and allowed to establish themselves for 24 hours as a 2-dimensional (2D) colony. Then (at Day 0), gelatin scaffolds (compartment 1, Figure 2b ) were placed on top of 2D macrophage colonies and left for 10 days so that macrophages could infiltrate the volume of the scaffold (Figure 3a) . On The inner compartment of this biomaterial system (Figure 2c ) was designed to provide delayed, on-demand, and magnetically triggered delivery of anti-inflammatory cytokines (e.g., IL-4 and IL-10). These biphasic ferrogels were designed so that cytokines could be loaded in hours). These magnetically stimulated release rates on days 4, 5, and 6 were significantly higher than control gels upon which no magnetic stimulation was applied (Figure 4f) . These 7 studies demonstrate our ability to control the timing and rate of these anti-inflammatory cytokine deliveries in an on-demand, magnetically prescribed manner.
The described biomaterial system could improve control over the inflammatory response in wound healing applications by locally regulating macrophage phenotype through carefully timed immunomodulatory cytokine deliveries. There is a growing preponderance of evidence suggesting that regulating macrophage phenotype vs. time is critical to achieving desired outcomes in wound healing and regenerative therapies, [32] [33] [34] [35] [36] and that sequenced deliveries of immunomodulatory cytokines can provide a means for this temporal regulation. [26, 37] In fact, previous studies have designed scaffolding materials to release proand anti-inflammatory cytokines at different rates in an attempt to temporally control macrophage phenotype. [19, [38] [39] [40] [41] While these studies yielded promising results in their ability to influence macrophage phenotype in vivo, statistically significant improvements in regeneration were not observed (e.g., larger or more well-organized vessels/tissues). This could have been due to the inability to explicitly alter and optimize the timing of different cytokine deliveries (i.e., having the delay time of anti-inflammatory cytokines be a variable parameter between conditions). The biomaterial system described here could enable explicit control over the timing of these deliveries, without having to alter the chemistry or structure of the implantable scaffold material between experiments. It should be noted, however, that with this material system's current formulation, macrophages initially recruited to the outer compartment may be exposed to baseline levels of anti-inflammatory cytokines diffusing out of the inner ferrogel ( Figure. formulation (e.g., porosity, polymer concentration, polymer type, crosslinking density). Such a tuned biomaterial system will need to be tested in order to verify that this material system is capable of temporally regulating macrophage phenotype through magnetic stimulation.
In sum, we have developed a biomaterial system capable of initially delivering proinflammatory cytokines (MCP-1 and IFN-γ) from a macroporous gelatin structure capable of facilitating macrophage infiltration and growth. The amount of inflammatory cytokine release was dependent on the amount of cytokine loaded in the structure. This biomaterial system was also integrated with a biphasic ferrogel that was capable of delivering anti-inflammatory cytokines (IL-4 and IL-10) in a delayed and magnetically triggered manner, using common hand-held magnets. The rate of magnetically stimulated delivery could be regulated by using different magnetic stimulation profiles and the timing of delivery could be regulated simply by choosing when to apply magnetic stimulation. This biomaterial system thus has the potential to enable experimental investigations into how the rate and timing of pro-and antiinflammatory cytokine deliveries impact biological process critical in wound healing applications. Finally, this material system could also provide the material means to therapeutically implement optimized sequential cytokine deliveries, while retaining a high degree of clinical adaptability by enabling real-time alterations in delivery profiles.
Experimental Section
Fabrication and imaging of the biomaterial system: The outer compartment gelatin scaffolds used in these studies were purchased as 2 x 12 x 7 mm GelFoam™ sponge sheets (Pfizer, Groton, CT) and cut into hollow disks (2-mm tall, 8-mm OD, 4-mm ID) using 8-mm and 4-mm biopsy punches. Note that biopsy punches and GelFoam sponges were packaged sterile for cell experiments. Additionally, they were packaged in lyophilized form, allowing them to be sputter-coated (30 seconds in gold) and imaged under Scanning Electron Microscopy (SEM) on a Zeiss SIGMA VP Field Emission-SEM with cryogenic capability and Energy-dispersive X-ray Spectroscopy (EDS) for elemental mapping.
The inner ferrogel compartments were made similarly to those described in Cezar et al. [28] Briefly, alginate was dissolved in MES buffer (100 mM MES and 500 mM NaCl at pH = 6.0) containing HOBT and AAD crosslinker and was cast with iron oxide particles and EDC (100 mg mL -1 ) between two Sigmacote-treated glass plates that were separated by 2-mm spacers. During casting (~ 1 hour), a magnet was placed against one glass plate as to pull the iron oxide particles towards one side of the gel, yielding a biphasic structure. Individual biphasic ferrogels were cut into 4 x 2 mm disks using a biopsy punch and then washed in 50 mL deionized water for 3 days (with water being exchanged twice a day) so that they would fully swell and become void of residual reagents. Ferrogels were then frozen at -20 ºC overnight and lyophilized. Lyophilized ferrogels were prepared for imaging by cross sectioning them using a sharp razor, sputter-coating in gold, and imaging as described above for the outer gelatin scaffolds. Cytokine time course release studies: Outer compartment gelatin scaffolds were unpacked and punched to shape in a lyophilized state. Thus, to load them with cytokine, concentrated solutions of protein were prepared and added dropwise directly to the dehydrated scaffolds. It was determined beforehand that when adding liquid to these scaffolds in this manner, they could fully absorb no more than 40 μL of solution. Thus, when loading the scaffolds, concentrated solutions were prepared such that the desired amount of protein to be loaded in the scaffold be contained in 40 μL volumes (e.g., 1000 ng MCP-1 loading required preparation of a concentrated solution of 1000 ng MCP-1 in 40 μL of PBS). So, scaffolds were placed in Sigmacote-treated scintillation vials (to limit protein adsorption to the surfaces of the vials) and loaded dropwise with concentrated protein solutions (MCP-1 or IFN-γ, prepared at concentrations as described above). Scintillation vials were then capped and the scaffolds were left overnight at room temperature to fully absorb the protein. Timecourse release studies began after overnight protein absorption when scaffolds were submerged in 1 mL PBS with 1% BSA (t = 0). 1 mL samples were collected periodically from the vials and reserved for analysis by freezing in 1.5 mL centrifuge tubes. After sample removal, fresh 1 mL of PBS with 1% BSA was gently added back to the vial until the next sample was taken. After all samples were collected (168 hours), they were thawed and quantified for cytokine content using ELISA.
Release studies from ferrogels followed a similar procedure. As described above, ferrogels were prepared with the final step being lyophilization, thus producing macroporous and dehydrated samples. Dried ferrogels were placed in scintillation vials with the Fe3O4-free region facing up. It was determined beforehand that when adding liquid to these ferrogels that they could fully absorb no more than 20 μL of solution. They were therefore loaded using desired weights of protein dissolved in 20 μL of PBS (e.g., 1000 ng IL-4 in 20 μL PBS). 12
Ferrogels were left to absorb the protein overnight in capped vials. Ferrogels were then rinsed in PBS with 1% BSA for 3 days to remove excess unincorporated protein, which reduced unstimulated baseline release. Ferrogels were then periodically sampled as described with the gelatin scaffolds, with sample media being fully removed and replaced with fresh media at each timepoint. Collected samples were quantitatively analyzed for IL-4 or IL-10 release using ELISA.
Statistical Analyses: All quantitative data presented in this communication are
represented as a mean ± standard deviation with 4 replicates (N = 4). Because only one-toone statistical comparisons were made in this study (i.e., no multiple comparisons), student ttests (two-tailed distributions, heteroscedastic) were used to calculate p-values with p < 0.05 being our benchmark for significance (Microsoft Excel). A two-compartment, magnetically responsive biomaterial system enables flexible control over the duration between pro-and anti-inflammatory cytokines deliveries. The system's outer porous gelatin compartment can facilitate rapid infiltration and harboring of macrophages. The system's outer compartment can be magnetically compressed, releasing payloads in earnest when stimulated with hand-held magnets. The combined 2-compartment system can release sequences of cytokines where the time between these two deliveries is controlled by the time at which a hand-held magnet is applied to the system. 
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